Latest / Resiliency Radio with Dr. Jill Carnahan, MD / 335: Resiliency Radio with Dr. Jill: The Cell Membrane: Your Body's Power Grid with Bob Miller
Transcript
- 0:04Dr. Jill Carnahan: Hey guys, welcome to Resiliency Radio, your go to podcast for the most cutting edge insights integrative and functional medicine.
- 0:12Dr. Jill Carnahan: I'm your host, Dr. Jill and with each episode we dive into the heart of healing and personal transformation.
- 0:18Dr. Jill Carnahan: Join me as I interview medical experts, world leaders, innovators of all types helping you on your journey to optimal performance and healing.
- 0:27Dr. Jill Carnahan: Today you're going to hear from one of my most repeat guests, some of the top episodes, Dr. Bob Miller, who goes into the genetics and different pathways.
- 0:36Dr. Jill Carnahan: Today we're going to be talking about a protein you may or may not know on the lipid bilayer.
- 0:40Dr. Jill Carnahan: It's called Cardiolipin, so stay tuned and if you haven't yet heard Dr. Bob, you will enjoy this episode.
- 0:47Dr. Jill Carnahan: Before we do, I just want to remind you we are accepting new patients at Flatiron Functional medicine in Louisville, Colorado.
- 0:53Dr. Jill Carnahan: You can call us at 303-993-7910 to schedule or you can go to email info flatironfunctionalmedicine.com you can meet our providers with a 10 minute free call if you prefer.
- 1:06Dr. Jill Carnahan: Or you can just get on the schedule and see one of us as an expert medical detective to help you solve your clinical problems.
- 1:14Dr. Jill Carnahan: Also, as you know products and services I offer@drjillhealth.com you can check that out for more things for your health, for your gut, for your brain, for your long Covid or whatever you're suffering.
- 1:24Dr. Jill Carnahan: Check it out there.
- 1:25Dr. Jill Carnahan: Get 15% off your first order.
- 1:27Dr. Jill Carnahan: And if you haven't yet ordered my book or checked out the Unexpected Finding Resilience through Functional Medicine, Science and Faith.
- 1:34Dr. Jill Carnahan: You can find that anywhere books are sold.
- 1:37Dr. Jill Carnahan: One of the most common feedback I've heard from the readers is I sat down and read it in one sitting.
- 1:43Dr. Jill Carnahan: So it tells my own story of overcoming Crohn's disease, cancer and mold related illness and all of the battles and difficulties that I overcame, but also the things that I learned in the process, the really practical tips including things like how deal with our old trauma and relationships and things that you might not expect.
- 2:03Dr. Jill Carnahan: So check it out wherever books are sold.
- 2:05Dr. Jill Carnahan: If you want a signed copy by me, just go to Dr. Jill Health and order it there.
- 2:11Dr. Jill Carnahan: Lastly, I just want to remind you that products and services@drjillhealth.com like our Ultra Hydrating Booster are available.
- 2:18Dr. Jill Carnahan: These are Dr. Jill Beauty products that are clean and effective.
- 2:21Dr. Jill Carnahan: They are some of our top selling products and I always want to remind people of that because they're some of My favorite things.
- 2:27Dr. Jill Carnahan: And I really love the beautiful labels there as well.
- 2:29Dr. Jill Carnahan: They're just happy.
- 2:30Dr. Jill Carnahan: They make me smile.
- 2:31Dr. Jill Carnahan: So hopefully they'll do the same for you.
- 2:34Dr. Jill Carnahan: Okay, let me introduce Bob Miller, a traditional naturopath specializing in the field of genetic specific nutrition.
- 2:40Dr. Jill Carnahan: In 1983, he opened Tree of Life, a practice and served as a traditional naturopath for 27 years.
- 2:46Dr. Jill Carnahan: He lectures nationally and internationally at seminars to educate healthcare practitioners about genetic variants.
- 2:51Dr. Jill Carnahan: If you've been on this channel, you have heard him before.
- 2:53Dr. Jill Carnahan: But let's dive right in with Cardiolipin with Bob Miller.
- 2:58Dr. Jill Carnahan: Bob, we're back again.
- 2:59Dr. Jill Carnahan: I don't know how many this is.
- 3:01Dr. Jill Carnahan: Now, you probably have the numbers of what we've done, but this is always such a fun episode, kind of different from our normal episode, but we're diving deep and you've got some really profound discoveries about the cell membrane that we're going to dive into.
- 3:15Dr. Jill Carnahan: So I'm just going to hand it right over to you.
- 3:18Dr. Jill Carnahan: And as always, we're like the talk show host, you know, back and forth.
- 3:22Dr. Jill Carnahan: I'm going to let you kind of go with it and then I will comment clinically as I see interesting things that you're sharing with us today.
- 3:30Bob Miller: Absolutely.
- 3:31Bob Miller: And this is number 14.
- 3:32Dr. Jill Carnahan: Amazing.
- 3:33Dr. Jill Carnahan: That's pretty.
- 3:34Dr. Jill Carnahan: Pretty amazing.
- 3:36Bob Miller: Yes.
- 3:37Bob Miller: So while you're seeing the screen.
- 3:39Dr. Jill Carnahan: I am, yes.
- 3:40Dr. Jill Carnahan: Looks great.
- 3:41Bob Miller: Yeah.
- 3:41Bob Miller: We're going to be talking about the cell membrane, your body's power grid.
- 3:46Bob Miller: Now, what's absolutely fascinating, Dr. Jill, is that, you know, we have been doing this, as I said, for a long time.
- 3:53Dr. Jill Carnahan: Yeah.
- 3:54Bob Miller: We started all the way back in 2020.
- 3:56Dr. Jill Carnahan: Wow.
- 3:56Bob Miller: Episode number 16.
- 3:59Bob Miller: And what's interesting is we've talked about, you know, things like the peroxy nitrite, the overstimulation of NOx IL6, upregulation of INOS that we call the carnage reaction, the heat oxygenase pathway, superoxide.
- 4:13Bob Miller: What's interesting, we're tying those all together now into one piece.
- 4:18Bob Miller: And I think everybody's going to be very surprised how we've taking all those things and tied them together.
- 4:27Bob Miller: So what we're going to learn, we're going to talk about the cell membrane.
- 4:30Bob Miller: We're going to talk about ATP, adenosine triphosphate, and we're going to learn how that's made in the electron transport chain.
- 4:38Bob Miller: And we're going to look at all the things you need for that.
- 4:41Bob Miller: The major focus today is going to be on an interesting membrane called cardiolipin, possibly people never even heard of this and by the time you're finished, you're going to understand why this cardiolipin is more important than we ever realized.
- 4:57Bob Miller: Then you also have what's called the lipid bilayer and how they get damaged by what's called lipid peroxidation, by peroxynitrite and hydroxyl radicals, things that we spoke about in previous webinars.
- 5:10Bob Miller: Then we're going to talk about that lipid peroxidation and calcium dysfunction, how it messes with how your calcium is used and then also how it changes your sodium potassium pump and the consequences that is.
- 5:22Bob Miller: And then we're going to tie that into glutamate and anxiety.
- 5:26Bob Miller: So put your seatbelt on folks, because here we go.
- 5:31Bob Miller: So I'm going to burn through these pretty quickly.
- 5:34Bob Miller: I'm not going to read them all.
- 5:36Bob Miller: So the cell membrane is a thin flexible barrier that surrounds every cell in your body.
- 5:41Bob Miller: It's made of a phospholipid bilayer.
- 5:43Bob Miller: Those are fats with water loving head and tails.
- 5:46Bob Miller: It keeps the cell safe and stable.
- 5:48Bob Miller: If you didn't have that, the cell would not be functioning.
- 5:51Bob Miller: It controls what enters and leaves.
- 5:53Bob Miller: It helps with communication, it supports the cell structure, enables specialized functions.
- 6:01Bob Miller: So obviously without cell membranes, cell couldn't keep their contents, exchange materials or communicate with each other.
- 6:08Bob Miller: We call it the foundation of life at the cellular level, keeping your body cells healthy, organized and able to work together.
- 6:19Bob Miller: Now the first step in making a cell membrane is the formation of a phospholipid bilayer.
- 6:24Bob Miller: As we said, we've got the heads and the tails and this creates a stable flexible barrier that makes life possible.
- 6:34Bob Miller: Now this bilayer serves as the scaffold for embedding proteins, carbohydrates and other molecules.
- 6:40Bob Miller: The functional plasma membrane that controls what enters and leaves the cell.
- 6:45Bob Miller: Proteins need to go in and out, controls fluidity with cholesterol, the glycoproteins.
- 6:50Bob Miller: And this chart to the right here shows what it actually looks like.
- 6:54Bob Miller: Where there's places where the nutrients go in and out based upon what's called the change in the gradient.
- 7:03Bob Miller: The your cell membrane is your life gate.
- 7:05Bob Miller: That's what we call it, that it lets in glucose, amino acids, your sodium, potassium and calcium, keeps out toxins, maintains membrane potential, houses receptors for your hormones, cytokines, neurotransmitters.
- 7:20Bob Miller: And if this gate fails, here's what happens.
- 7:23Bob Miller: Dr. Jill There goes your energy, your communication and your structural integrity.
- 7:30Bob Miller: The cell membrane is your life gate because it controls energy flow, information flow, the ion Balance inflammatory signaling.
- 7:40Bob Miller: If it's healthy, the cell adapts, repairs and survives.
- 7:44Bob Miller: If it's damaged, the cell becomes inflamed, dysregulated and eventually dies.
- 7:49Bob Miller: And that is the dying process when the cells start falling apart.
- 7:54Bob Miller: All right, I knew I burned through that pretty quickly, but I want to talk about.
- 7:59Dr. Jill Carnahan: Well, that's so important, Bob.
- 8:00Dr. Jill Carnahan: I just want to just.
- 8:01Dr. Jill Carnahan: We've talked before about these things, but this is at such a core level of every cell in the body.
- 8:07Dr. Jill Carnahan: How it communicates, how it acts in conjunction.
- 8:11Dr. Jill Carnahan: And we've known for many years as well that all.
- 8:14Dr. Jill Carnahan: I'm sure you're going to go into all the things that damage these membranes, but this is really a core concept, so I want people listening to realize that this is at the core of so, so many complex chronic diseases.
- 8:24Dr. Jill Carnahan: Go on.
- 8:25Bob Miller: Absolutely.
- 8:26Bob Miller: Well, we want to talk about ATP, adenosine triphosphate.
- 8:29Bob Miller: People have probably heard that.
- 8:30Bob Miller: I mean, they learned that in high school biology.
- 8:33Bob Miller: But it's good to review your brain, your lungs, your kidneys, your digestive system, your immune system, reproductive, all your cells, the nervous system, the skin, the skeletal system, the muscles, the liver, the heart, the.
- 8:47Bob Miller: They all need ATP.
- 8:50Bob Miller: And if we theoretically had an ATP switch, which we don't have, obviously, but if we switch that to off, everything would just stop because everything depends upon that ATP.
- 9:02Bob Miller: And that's what we're going to be talking about in this webinar.
- 9:05Bob Miller: All right, now, we just spoke about how ATP is so important.
- 9:08Bob Miller: Now, I know many times if we talked about ATP in the past, we said, oh, yeah, that's responsible for your muscle energy.
- 9:14Bob Miller: But look at this list.
- 9:15Bob Miller: Not only energy.
- 9:17Bob Miller: If the low ATP, you're going to have increased inflammation, lowered repair, lowered resistance, fatigue, your sodium, potassium balance goes off, your calcium regulation goes off, you're going to become anxious, and we're going to talk about that a little bit.
- 9:32Bob Miller: There's something called glial cells that'll give persistent inflammation.
- 9:36Dr. Jill Carnahan: So, Bob, pause right there really quickly.
- 9:38Dr. Jill Carnahan: ATP.
- 9:38Dr. Jill Carnahan: We know about energy.
- 9:39Dr. Jill Carnahan: You've got these incredible lists, but you just said something that I think you're going to talk more about later.
- 9:44Dr. Jill Carnahan: Problems with ATP could actually cause anxiety.
- 9:46Dr. Jill Carnahan: Is that true?
- 9:47Bob Miller: Yes.
- 9:49Dr. Jill Carnahan: Brilliant.
- 9:52Bob Miller: So we're going to get into this.
- 9:53Bob Miller: Impaired neurotransmitter balance in neurons creates anxiety, impaired glial cell function, impaired protein synthesis, reduced antioxidants, cell loss and organ dysfunction.
- 10:05Bob Miller: Decreased immune function, reduced muscle function, impaired digestion.
- 10:11Bob Miller: Restore ATP and you restore life.
- 10:15Bob Miller: I'm going to tie this into why the Three major things that we're seeing today is mold getting stronger, Lyme disease, spike protein.
- 10:23Bob Miller: And I'm going to tie that all together as to why that's attacking our ATP.
- 10:29Bob Miller: Now, we're going to talk now about how you make ATP.
- 10:34Bob Miller: There's something called the electronic transport chain, and we'll try to make this simple.
- 10:40Bob Miller: They're called complexes, and there's five of them.
- 10:45Bob Miller: And what happens is electrons that come from something called NADH flow through what's called an iron sulfur cluster.
- 10:55Bob Miller: We're going to talk about that.
- 10:57Bob Miller: It also needs heme.
- 10:59Bob Miller: And then what happens is these protons get pushed into the inner cell membrane and each one pushes a little bit out and then they come back in number five and make your ATP.
- 11:12Bob Miller: So what we're going to be talking about today, Dr. Jill, is what can go wrong here?
- 11:17Bob Miller: And there's a heck of a lot that can go wrong.
- 11:20Bob Miller: So nadh.
- 11:21Bob Miller: Now, I would encourage people to go back and look at one of our, the last webinar we did, and that was on the importance of nadph.
- 11:30Bob Miller: So your NADH is what provides that electron that pushes it.
- 11:37Bob Miller: So that's how it's made.
- 11:40Bob Miller: Now look what happens if we have low nadh, which many people do.
- 11:44Bob Miller: We in our clinic, we measure the nadph.
- 11:49Bob Miller: And if you got low nadh, you're not going to be pushing those protons up and you're going to have low energy.
- 11:58Bob Miller: So it's episode number 270.
- 12:00Bob Miller: I encourage people to go back and watch that one.
- 12:03Bob Miller: We really dig in deeply into nadph.
- 12:08Bob Miller: We don't have time for it today, but encourage you to watch episode number 270.
- 12:13Bob Miller: So that's if we have low NADH.
- 12:16Bob Miller: Now, on the other hand, in episode number 270, we talked about that you can have too much NADH if it doesn't get turned back to nad.
- 12:26Bob Miller: That can be just as bad because the electrons back up and then they'll actually come back to a complex one.
- 12:34Bob Miller: And we'll talk about this later.
- 12:36Bob Miller: The electron leaks off and makes a free radical called superoxide.
- 12:42Dr. Jill Carnahan: Yes.
- 12:42Bob Miller: Now, again, I would encourage everybody go back and watch our video.
- 12:46Bob Miller: I think we spoke like for an hour and 15 minutes on superoxide.
- 12:50Bob Miller: So you see how this is all tying together.
- 12:53Bob Miller: So if we have balanced nadh, sort of like Goldilocks and the three bears, not too much, not too little, then the protons fly out, they come back in, and we have plenty of ATP.
- 13:09Bob Miller: So it's really critical that we have this Nedh balanced again, episode 270.
- 13:16Bob Miller: Watch that to learn all the complexities of that.
- 13:21Bob Miller: Now, Coq10, I'm sure most people have heard about Coq10.
- 13:25Bob Miller: Coq10 is part of the shuttle that takes that electron.
- 13:29Bob Miller: So you can see one and two here.
- 13:31Bob Miller: Start donating, they hand it over to three.
- 13:34Bob Miller: And we could probably do a whole episode on Coq 10.
- 13:38Bob Miller: But just briefly, it's in two forms and between reduced and oxidized.
- 13:43Bob Miller: So we have to have enough CoQ10.
- 13:46Bob Miller: Well, guess what?
- 13:47Bob Miller: You can have genetic SNP single nucleotide polymorphisms that impair the efficient creation and utilization of CoQ10.
- 13:56Bob Miller: So if you don't have enough CoQ10 here, you're not getting the whole way down here and you're going to be tired.
- 14:04Bob Miller: Now, also, heme.
- 14:07Bob Miller: Now what's interesting, episode number 119, we spoke about heme and heme plays a lot of roles, but I'm just referring to it right here.
- 14:17Bob Miller: You can see it's in complex two, complex three, complex four.
- 14:24Bob Miller: So if you don't have enough heme, then you're also not going to have those protons go up and make your ATP.
- 14:32Bob Miller: So here we say inadequate heme can therefore impair electron flow, lower ATP production and increase electron leakage and oxidative stress.
- 14:42Bob Miller: And guess what?
- 14:43Bob Miller: You can have genetic weakness in the heme cycle.
- 14:46Bob Miller: And we talk about that in episode number 119.
- 14:51Bob Miller: Now here's what we spoke about in that episode.
- 14:53Bob Miller: I'm not going to go through it here, but this is the pathway in which you make that hemet.
- 15:00Bob Miller: And for example, you can have lead exposure which will impair this.
- 15:05Bob Miller: You can have genetic SNPs, mutations.
- 15:07Bob Miller: All of that will impact your body's production of heme.
- 15:12Bob Miller: So here's another way that your ATP can be lowered.
- 15:16Bob Miller: Now this is one that I'm absolutely fascinated.
- 15:19Dr. Jill Carnahan: Now, Bob, I'm going to ask really a quick question about heme.
- 15:22Dr. Jill Carnahan: And this may be a silly question, but I bet if those people listening might have the same question.
- 15:27Dr. Jill Carnahan: Heme, how is that related to iron and ferritin directly?
- 15:29Dr. Jill Carnahan: If you're measuring that in the blood, a different particle or is it actually believe.
- 15:34Bob Miller: Yeah, I do believe it's.
- 15:35Bob Miller: It's different than your iron or ferritin.
- 15:37Bob Miller: Yes.
- 15:38Bob Miller: Well, I want to go back to that episode and watch that.
- 15:40Bob Miller: I think we perfect in there.
- 15:42Bob Miller: Yeah.
- 15:43Bob Miller: Now this one I'm absolutely excited about.
- 15:47Bob Miller: Nobody's talking about the iron sulfur cluster.
- 15:52Bob Miller: And what that means is that iron and Sulfur.
- 15:57Bob Miller: Combine together four irons, four sulfurs, and make an iron sulfur cluster.
- 16:03Bob Miller: And you can see here it is in complex 1, 2, and 3.
- 16:10Bob Miller: And if we don't have the iron sulfur cluster, this is what helps those electrons flow.
- 16:17Bob Miller: And if you don't have that, this isn't going to flow.
- 16:20Bob Miller: So I'm sure, Dr. Jill, one of the most, you know, biggest complaints you hear from some of your patients is they're tired.
- 16:26Dr. Jill Carnahan: Yes.
- 16:27Bob Miller: They're fatigued.
- 16:28Bob Miller: Well, you can see there's a lot that can go wrong here.
- 16:32Bob Miller: So here it says when iron sulfur clusters are deficient, electron transfer becomes less efficient, increasing the leakage and superoxide formation while reducing the proton gradient needed to make ATP.
- 16:48Bob Miller: Yeah.
- 16:48Bob Miller: So again, you don't have these protons going up to come down here to make ATP.
- 16:53Bob Miller: Then on top of that, the electron leaks off.
- 16:56Bob Miller: And I'm going to show that later, making superoxide.
- 16:59Bob Miller: And again, please go back and watch our episode on superoxide.
- 17:02Bob Miller: So you understand the significance of that?
- 17:04Dr. Jill Carnahan: Yes.
- 17:05Bob Miller: Now, here is how we make the iron sulfur cluster.
- 17:09Bob Miller: This is complex, Dr. Dill.
- 17:12Bob Miller: So you'll see up here we have iron import, and these are what are called solute carriers that create the mitochondrial iron pool.
- 17:21Bob Miller: Then there's an enzyme called FXN Fertaxin, which you can also have genetic SNPs on, that provides the iron.
- 17:32Bob Miller: Then you need cysteine.
- 17:35Bob Miller: And through the enzyme NFS1, you can have SNPs here, provides the sulfur.
- 17:42Bob Miller: But you also need an electron and a dph.
- 17:47Bob Miller: So if you're having trouble with your nad, and you're low in nadph, you're not donating the electron.
- 17:54Dr. Jill Carnahan: Yeah, it's like a little recipe equation.
- 17:58Bob Miller: So then these are the genes we won't get into this, but these are the ones that actually assemble.
- 18:03Bob Miller: And when it comes out of here, it's two FES, two Ss, two sulfurs.
- 18:09Bob Miller: And then through this process, we get it into the four FE4s.
- 18:16Bob Miller: But look who's here.
- 18:18Bob Miller: Glutathione redoxase number five.
- 18:22Bob Miller: So if we don't have enough glutathione, we don't get from 2 to 4.
- 18:29Bob Miller: And then through these enzymes right here.
- 18:33Bob Miller: And if you want, and you can have genetic SNPs here, it hands it over to complex one.
- 18:43Bob Miller: Now, what we've been seeing is we're looking at this.
- 18:46Bob Miller: I am stunned for how many people.
- 18:48Bob Miller: This is their issue.
- 18:51Bob Miller: And when we're at the end, we're going to.
- 18:53Bob Miller: You're so brave.
- 18:54Bob Miller: We're going to look at your genome, and I'm going to show you why this might be something you need to look at.
- 18:58Bob Miller: Dr. Jill.
- 18:59Dr. Jill Carnahan: Oh, excellent.
- 19:01Bob Miller: Now, here's what we need.
- 19:03Bob Miller: If we have iron that's too high and cysteine too low, you're going to have not enough clusters, and you're going to be making what are called hydroxyl radicals.
- 19:15Bob Miller: We spoke about that in our very first webinar.
- 19:18Bob Miller: If ideally, they're balanced, everything's good, you're going to have adequate ATP, low inflammation, everything's going good.
- 19:27Bob Miller: If you would have low iron and high cysteine for your sulfur, again, you're going to have a problem.
- 19:33Bob Miller: And if they're both low, you're going to have a problem.
- 19:37Dr. Jill Carnahan: Okay, this is fascinating.
- 19:38Dr. Jill Carnahan: Again, it's so clear, and I want to just mention people out there might not know cysteine.
- 19:42Dr. Jill Carnahan: NAC is a form of cysteine that we take as a supplement.
- 19:46Dr. Jill Carnahan: And this is why I've always known in clinical practice, and you and I have talked about other scenarios, Bob, where it's Goldilocks.
- 19:52Dr. Jill Carnahan: Sometimes you just think, oh, I need NAC because it's a precursor of glutathione, and everybody takes it, or they take a lot of it.
- 19:58Dr. Jill Carnahan: And in this scenario, for example, number three, if you took two too much and you had low iron, it may be a problem.
- 20:05Bob Miller: You're right, Goldilocks.
- 20:07Bob Miller: Not too hot, not too cold.
- 20:10Bob Miller: All right, now, here's what can happen.
- 20:13Bob Miller: We're living in a different world.
- 20:14Bob Miller: I often tell people that I was born in a different world.
- 20:18Bob Miller: In 1954, we didn't have so many of the things that we have now.
- 20:22Bob Miller: Today we have the spike protein.
- 20:25Bob Miller: This very well may have changed things dramatically.
- 20:29Bob Miller: Yes, there's a lot of people that do believe mycotoxins are getting stronger.
- 20:34Bob Miller: And then Lyme disease seems to be rampant.
- 20:37Bob Miller: Now, there's many things that'll trigger this, but these, I think, are the big three.
- 20:41Dr. Jill Carnahan: Yeah.
- 20:42Bob Miller: And that stimulates tumor necrosis factor, which is an enzyme that's inflammatory part of your immune system.
- 20:49Bob Miller: But again, Goldilocks, if it's too active, we have a problem.
- 20:52Bob Miller: Then it stimulates NF kappa B.
- 20:54Bob Miller: This is the core enzyme that starts putting off inflammation.
- 20:59Bob Miller: It stimulates NOx.
- 21:00Bob Miller: Again, this is one of our.
- 21:03Bob Miller: This is one of our webinars.
- 21:04Bob Miller: Early on, it stimulates inos.
- 21:06Bob Miller: This is Carnahan reaction that we where too much nos 2.
- 21:14Bob Miller: So if you get superoxide nitric oxide, we get peroxy nitrite.
- 21:20Bob Miller: Ironically.
- 21:21Bob Miller: Oh, no, it's the.
- 21:23Bob Miller: Is the symbol for it that will then start destroying the iron sulfur cluster.
- 21:29Bob Miller: That isn't the end of it.
- 21:30Bob Miller: That iron gets released and iron is your best friend, unless it's your worst enemy.
- 21:36Bob Miller: Because if it's floating around on its own, it can be very inflammatory and it will come back and stimulate tnfa.
- 21:44Bob Miller: Then through the Fenton reaction, hydroxyl radicals combine and make hydroxyl radicals.
- 21:51Bob Miller: That does more damage to the lipid bilayer.
- 21:57Bob Miller: So here you can see if you've got plenty of iron sulfur clusters.
- 22:02Bob Miller: Everything's going good.
- 22:04Bob Miller: If you don't.
- 22:06Bob Miller: Impaired electron transfer, proton leak, loss of gradients, reduced ATP, increased reactive oxygen species.
- 22:15Bob Miller: And when those electrons leak off, rather than make energy, I'm going to show you later how that can create quite the problem.
- 22:23Bob Miller: And then you're going to have loss of that membrane integrity.
- 22:27Bob Miller: And remember, we said that membrane integrity is one of the most important things we need to have.
- 22:33Bob Miller: Now, if you wouldn't think that's enough, there's.
- 22:36Bob Miller: There's more.
- 22:37Bob Miller: There's something called the Krebs cycle, and this is really important because this is part of our energy production.
- 22:44Bob Miller: It makes many of the things that your electron transport chain needs.
- 22:49Bob Miller: But interestingly, there's an enzyme called ACO2, and it needs the iron sulfur cluster to turn what's called cisactinate into isocitrate.
- 23:02Bob Miller: And if that happens, you're going to have adequate NADH production.
- 23:07Bob Miller: You're going to support your ATP.
- 23:09Bob Miller: Everything is going good.
- 23:11Bob Miller: But look what happens if your iron sulfur cluster is damaged.
- 23:16Bob Miller: It doesn't happen.
- 23:18Bob Miller: There's going to be citrate buildup, reduced Krebs cycle flux, less nadh, lowered ATP, more oxidative stress.
- 23:28Bob Miller: When we came across that one was like, that's a big deal.
- 23:33Bob Miller: If your Krebs cycle is not spinning, you're going to be tired.
- 23:37Dr. Jill Carnahan: Yes.
- 23:37Bob Miller: We'll try to take all kinds of stimulants and other things and either they don't work or they backfire.
- 23:43Dr. Jill Carnahan: Yes.
- 23:44Bob Miller: Because you're.
- 23:44Bob Miller: I'm sure you've heard that many times.
- 23:46Bob Miller: Oh, I took.
- 23:46Bob Miller: I can't take vitamins because they react to them.
- 23:50Bob Miller: Yeah, there's many reasons, but this could be one of them.
- 23:52Bob Miller: When you start pushing this and you're stuck here.
- 23:56Dr. Jill Carnahan: Right, Exactly.
- 23:59Bob Miller: It's not going to go now.
- 24:00Bob Miller: I'm not going to read each of these, but I'm going to burn through them very quickly.
- 24:04Bob Miller: But it just shows all the body systems that are impacted by the iron sulfur cluster.
- 24:11Bob Miller: We're going to start with the lungs.
- 24:13Bob Miller: If it's damaged, we're going to have electron leaks, ATP declines, lung stress and dysfunction, fatigue or exercise intolerance, airway irritation, pulmonary stress, the brain, same thing.
- 24:29Bob Miller: Brain fog, neurotransmitters, excitability imbalance, neuroinflammation risk, neurodegenerative stress.
- 24:38Bob Miller: All that happens if you don't have enough iron sulfur clusters, that affects the brain.
- 24:43Bob Miller: Here's the kidneys, where reabsorption, electrolyte imbalance, fluid dysregulation, kidney injury and risk.
- 24:52Bob Miller: Then here we have the liver fatigue or detoxification, fatty liver risk, metabolic stress, all if you don't have that iron sulfur cluster delivering those electrons.
- 25:06Bob Miller: Now this is probably going to be the most important thing we're going to talk about in this podcast.
- 25:11Bob Miller: Yes, cardiolipin.
- 25:15Bob Miller: It's a specialized phospholipid found mainly in the inner mitochondrial membrane where the electron transport is located.
- 25:22Bob Miller: Now, I'm not going to read all these enzymes.
- 25:24Bob Miller: These are the ones that make, helps organize.
- 25:27Bob Miller: This is key points.
- 25:28Bob Miller: This may be the most important thing we're saying in this whole webinar.
- 25:32Bob Miller: Helps organize and stabilize the electron transport chain complexes.
- 25:37Bob Miller: And we'll talk a little bit about super complexes.
- 25:40Bob Miller: Supports efficient electron transfer and proton pumping and helps maintain the membrane structure needed to generate ATP.
- 25:49Bob Miller: So now I'm beginning to believe that having adequate manufacturing of cardiolipin and not destroying it might be one of the most important things we should put to the top of our list when we're dealing with dysfunction.
- 26:05Dr. Jill Carnahan: Hey guys, just a reminder, you can find products and services@drjillhealth.com Things like the detox bundle, the Epstein Barr bundle and many other things for your gut, for your brain, or for whatever might ail you.
- 26:17Dr. Jill Carnahan: Go to Dr. Jill health.com get 15% off your first order.
- 26:21Dr. Jill Carnahan: And let's get back to the show with Dr. Bob.
- 26:25Dr. Jill Carnahan: Yes, and Bob, in clinical experience, I'm sure you're going to go to this, but what I see since Spikes since Molten's that I am actually regularly testing every patient for anticardiolipin antibodies because as you have this damaged membrane, the body's like, whoa, what's going on with that?
- 26:39Dr. Jill Carnahan: And again, I'm sure you'll explain more about this then often you get autoantibodies to that and to me that's a sign not of lupus, although that can be, but more of damage to these membranes and I have to actually intervene and think about what needs to be done.
- 26:56Dr. Jill Carnahan: So there are tests that can measure some of these processes to the cardiolipin.
- 27:01Bob Miller: Mm.
- 27:02Bob Miller: Yeah.
- 27:02Bob Miller: You can't measure cardiolipin itself, but as you said, you can measure the cardiolipin antibodies.
- 27:07Dr. Jill Carnahan: Yeah.
- 27:07Bob Miller: So if the cardiolipin falls out of the membrane immune system says who the heck are you?
- 27:12Dr. Jill Carnahan: What's going on?
- 27:12Dr. Jill Carnahan: Exactly.
- 27:13Dr. Jill Carnahan: Exactly.
- 27:14Dr. Jill Carnahan: And well.
- 27:15Dr. Jill Carnahan: Sorry, go ahead, Bob.
- 27:16Bob Miller: Oh, and then you start attacking what one of the most important molecules might be in the body.
- 27:21Dr. Jill Carnahan: Yes.
- 27:21Dr. Jill Carnahan: And again, you can speak to this later.
- 27:23Dr. Jill Carnahan: When you talk about my genetics, I always share to you guys listening out here who haven't heard of Bob and I episode, I always put my genetics right out there for the public to see.
- 27:31Dr. Jill Carnahan: Really transparent.
- 27:32Dr. Jill Carnahan: But what I was going to say is after my first significant COVID infection, I developed anticardiolipin antibodies.
- 27:38Dr. Jill Carnahan: Surprise, surprise, fries.
- 27:41Bob Miller: Well, that's interesting.
- 27:42Dr. Jill Carnahan: Yeah.
- 27:44Bob Miller: So here we go.
- 27:45Bob Miller: Neurological disorders, neuropsychiatric disorders, mitochondrial issues, cardiovascular issues, metabolic disorders, skeletal muscle disorders, immune disorders, autoimmune, gastrointestinal liver, kidney, endocrine, fertility, aging.
- 28:01Dr. Jill Carnahan: Wow.
- 28:02Bob Miller: Aging is cumulative.
- 28:03Bob Miller: Cardiolipin oxidation.
- 28:05Bob Miller: Even cardiolipin abnormalities can have a complex relationship with cancer.
- 28:10Bob Miller: And vision disorders.
- 28:12Dr. Jill Carnahan: Wow.
- 28:12Bob Miller: Hearing disorders, pulmonary disorders, blood disorders, rare genetic disorders, all of that can be related.
- 28:19Bob Miller: Now, cardiolipin isn't the only piece, but it's likely a contributing factor to all of those conditions.
- 28:26Bob Miller: So that's why our research team is saying, you know what, we need to really make sure we are making and taking care of our cardiolipin.
- 28:35Dr. Jill Carnahan: Yeah.
- 28:37Bob Miller: Because when it's exposed, it can even directly talk to NLRP 3.
- 28:41Bob Miller: We spoke about that in another webinar, helping recruit and activate the inflammasomes and trigger more inflammatory signaling.
- 28:50Bob Miller: That's why we have our little yikes over here.
- 28:53Dr. Jill Carnahan: Yeah.
- 28:54Bob Miller: So you can see how this thing just keeps spinning.
- 28:57Bob Miller: So mitochondrial stress leads to the NLRP3 recruitment inflammasome activation.
- 29:05Bob Miller: So look at all cardiolipin helps to do.
- 29:07Bob Miller: Organizes the inner mitochondrial membrane, anchors the electron transport complexes, stabilizes the super complexes.
- 29:16Bob Miller: So let's talk about that a little bit.
- 29:18Bob Miller: As I showed you before, there's a little space between the complexes and that's where electrons can leak off.
- 29:27Bob Miller: When there's adequate cardiolipin, they get closer together and there's less chance for leakage.
- 29:34Bob Miller: So you're going to have more ATP.
- 29:36Bob Miller: It's believed that people who are naturally athletic have that going on, that their complexes are close to each other and there's plenty of ATP.
- 29:46Bob Miller: And not having the.
- 29:48Bob Miller: And not having the leakage.
- 29:51Bob Miller: So improved electron transfer efficiency.
- 29:54Bob Miller: Leakage decreasing your superoxide production, maximizing your ATP, supporting the proton retention, regulating aptosis, the death of the cells, supporting autophagy of the recycling and maintaining the structure of the membrane.
- 30:10Bob Miller: All of that's related to cardiolipin.
- 30:13Bob Miller: Now we could probably do a whole webinar on just cardiolipin, but there's something called cytochrome C, which is also part of the electron transfer.
- 30:28Bob Miller: And if there's not enough cardiolipin, cytochrome C falls out of the inner membrane and then that is really making apoptosis where mitochondria are actually damaged.
- 30:41Bob Miller: Interestingly, this is where red light therapy is shining.
- 30:44Bob Miller: no pun intended, right?
- 30:46Bob Miller: Yes, yes, the red light helps keep that cytochrome C into place.
- 30:51Bob Miller: That's why red light therapy has become so popular.
- 30:56Bob Miller: Now again, we could spend a whole webinar on talking about this, but this is how your cardiolipin gets made.
- 31:08Bob Miller: The final step being here.
- 31:10Bob Miller: But you also need some of your essential fatty acids and they're controlled by FADS two and FADS one.
- 31:18Bob Miller: One of the things we are finding is that people who are really struggling have genetic snips in FADS two and FADS one.
- 31:26Bob Miller: Therefore they're not getting the polyunsaturated fatty acids over here.
- 31:31Bob Miller: So this final step, they call this tas, it combines these two together to make your mature cardiolipin.
- 31:40Bob Miller: So we oftentimes see people that.
- 31:43Bob Miller: I just spoke to a 40 some year old woman today who, her sister died of a heart attack at 44.
- 31:49Bob Miller: She's having heart problems.
- 31:51Dr. Jill Carnahan: Wow.
- 31:51Bob Miller: She was homozygous on just about every fads, so she was not making cardinalipin and creating all kinds of problems.
- 32:03Bob Miller: So now lipid peroxidation.
- 32:05Bob Miller: Again, this is probably the key thing we need to focus on today.
- 32:10Bob Miller: That's where reactive oxygen species.
- 32:12Bob Miller: Here we go back to what we spoke about six years ago.
- 32:16Dr. Jill Carnahan: Yes.
- 32:16Bob Miller: Hydroxyl radicals, superoxide and peroxy nitrite attack the fatty acids within the cell and mitochondrial membranes.
- 32:25Bob Miller: This, Dr. Jill, might be the most important things we've said today.
- 32:30Bob Miller: When that cardiolipin gets damaged, it destabilizes the membrane proteins and ion transport impairs the electron transport chain, lowers ATP, increases electron leakage and superoxide generation.
- 32:46Bob Miller: Then it makes aldehydes such as 4HNe and MDA, which can further damage proteins, enzymes, DNA and mitochondrial structures, contributing to calcium dysregulation that we're going to get to next, inflammation, oxidative stress, and progressive cellular dysfunction.
- 33:02Bob Miller: See how this is all tying together here, Dr. Jill?
- 33:06Bob Miller: This might be one of the more important slides we're going to show as well.
- 33:10Bob Miller: So here's your cell membrane, your lipid bilayer.
- 33:15Bob Miller: Here's your cardiolipin.
- 33:17Bob Miller: And when we make superoxide from Nox, I think this is our second webinar we did.
- 33:25Bob Miller: When the electrons leak, when we combine to make peroxy nitrite, or if we get iron combining with hydrogen peroxide, we make hydroxyl radicals.
- 33:35Bob Miller: There's another one called alox that we won't get into today.
- 33:38Bob Miller: They will start damaging the bilayer by grabbing a hydrogen.
- 33:43Bob Miller: We call that the spark.
- 33:45Bob Miller: By the way, this is Mr. Sparky over here.
- 33:47Dr. Jill Carnahan: yes.
- 33:48Bob Miller: Then the propagation, where it just keeps feeding on itself until we bring out the firefighters.
- 33:57Bob Miller: And that includes things like vitamin E. I particularly like Delta Gold, K2, Astaxanthin, CoQ10 and Glutathione.
- 34:06Bob Miller: They're the firefighters, particularly astaxanthin.
- 34:09Bob Miller: It actually protects the entire cell membrane where a vitamin E just protects part of it.
- 34:15Bob Miller: So we've been finding pretty nice improvements.
- 34:18Bob Miller: When you turn off the blowtorch and you bring out the firefighters, this very well may be step number one.
- 34:28Bob Miller: So I know a lot of folks are like, oh, you've got mold.
- 34:30Bob Miller: We've got a detox mold.
- 34:31Bob Miller: Oh, you've got Candida.
- 34:32Bob Miller: Oh, you've got heavy metals.
- 34:34Bob Miller: Well, if this is malfunctioning and the eliminating organs aren't getting the power, it can be very difficult to do.
- 34:41Dr. Jill Carnahan: Yes, that makes sense.
- 34:42Bob Miller: I'm putting out that hypothesis that maybe this is step number one.
- 34:48Dr. Jill Carnahan: Yeah.
- 34:48Bob Miller: Before you try to do anything else too heroic.
- 34:51Dr. Jill Carnahan: And I think this is why Patricia Kane's work on cell membrane restoration has been so powerful in all of these years of any practitioner doing these kind of mold or Lyme or Long Covid.
- 35:01Dr. Jill Carnahan: Because it focuses on this very topic, which is cell membrane restoration.
- 35:07Bob Miller: Yes.
- 35:07Bob Miller: I've been posting this on my.
- 35:09Bob Miller: My Facebook page, and she's actually been jumping in and giving.
- 35:11Dr. Jill Carnahan: Yay.
- 35:12Dr. Jill Carnahan: She's probably like, yes, Bob, you're bringing evidence to what I've been doing for years.
- 35:16Dr. Jill Carnahan: It's amazing.
- 35:16Dr. Jill Carnahan: But I mean, you've got the.
- 35:17Dr. Jill Carnahan: She.
- 35:18Dr. Jill Carnahan: She obviously knew it worked, but you're bringing a whole new level of understanding to the topic.
- 35:23Bob Miller: Yeah.
- 35:24Bob Miller: And I believe when.
- 35:25Bob Miller: When co came along, that's stimulating this.
- 35:28Bob Miller: The mycotoxin stimulate this.
- 35:30Bob Miller: Lyme stimulates this epic storm.
- 35:32Bob Miller: So I believe that's why we might be in a new world here that things that maybe worked in the past aren't going to work quite as well until we address this.
- 35:43Bob Miller: Step number one here, Dr. Jill.
- 35:46Bob Miller: All right, now here's another.
- 35:48Bob Miller: This is one of my favorite pictures.
- 35:51Bob Miller: When.
- 35:51Bob Miller: Here's the complexes again.
- 35:53Bob Miller: Here's the protons, here's the electrons flowing.
- 35:56Bob Miller: Here's CoQ10, your cytochrome C making the ATP.
- 36:02Bob Miller: This represents your cardiolipin.
- 36:06Bob Miller: If cardiolipin gets damaged, these electrons don't make ATP, they leak off.
- 36:15Bob Miller: This is important.
- 36:16Bob Miller: Combined with oxygen to make superoxide, then combined with nitric oxide to make peroxy nitrite.
- 36:23Bob Miller: By the way, nitric oxide isn't a bad guy.
- 36:24Bob Miller: It's very good for us.
- 36:26Dr. Jill Carnahan: Right?
- 36:26Bob Miller: Except that when it combines with superoxide, then it becomes.
- 36:30Bob Miller: Oh, no, Peroxy nitrite.
- 36:32Bob Miller: And there was some thought that peroxinitrite wasn't as dangerous, but we're now finding it.
- 36:37Bob Miller: It really is, with new scientific research.
- 36:40Bob Miller: Then oxidizes your cardiolipin, damages the cardiolipin.
- 36:45Bob Miller: And what do you have here, Dr. Jill?
- 36:47Bob Miller: A feedback loop.
- 36:49Bob Miller: A vicious feedback loop that as you damage the cardiolipin, there's more leakage.
- 36:56Bob Miller: More leakage leads to more cardiolipin, and around we go.
- 37:01Bob Miller: This may be the key point of this podcast.
- 37:05Bob Miller: Wow.
- 37:06Bob Miller: If this is going on, you gotta stop it.
- 37:11Bob Miller: Because if you don't, many things that you're going to try may not work.
- 37:16Dr. Jill Carnahan: Correct.
- 37:17Bob Miller: So stopping this is critical.
- 37:21Bob Miller: Isn't that absolutely fascinating, Dr. Jill?
- 37:23Dr. Jill Carnahan: It makes so much sense, Bob.
- 37:25Dr. Jill Carnahan: I love how we keep going.
- 37:26Dr. Jill Carnahan: It's like the Russian dolls.
- 37:28Dr. Jill Carnahan: You said we keep going, you know, lower into you open one, and they're like, oh, there's more.
- 37:33Dr. Jill Carnahan: Open one, there's more.
- 37:34Dr. Jill Carnahan: And as you get to the depth of this, and this is such an essential cell membrane, even the cell danger response by Navio was all around when cell membranes get damaged and ATP leaks outside the cell, it triggers this response, which this is at the core if we can prevent this cardio damaged.
- 37:52Dr. Jill Carnahan: So tell us more.
- 37:53Dr. Jill Carnahan: How do we.
- 37:54Dr. Jill Carnahan: How do we deal with this?
- 37:55Bob Miller: Okay, here we go.
- 37:58Bob Miller: So this is just a little drawing on how the cardiolipin gets damaged from peroxinitrite.
- 38:03Bob Miller: Here again, spikes mycotoxins.
- 38:06Bob Miller: Lyme stimulates microglia M1, TNFA, NF, Kappa B.
- 38:12Bob Miller: Here's your inflammasomes.
- 38:14Bob Miller: Stimulates NOX and Inos.
- 38:16Bob Miller: Then peroxinitrite.
- 38:18Bob Miller: Oh, no.
- 38:19Bob Miller: Damages the cardiolipin, lipid peroxidation and again, genetic SNPs.
- 38:24Bob Miller: If you got gain of function on TNFA, gain a function in F kappa B, gain a function NLRP 3, gain a function IL 6, gain a function here.
- 38:34Bob Miller: Two people could be exposed to the same thing.
- 38:37Bob Miller: But if one person has genetic gain of functions here, they're going to be more impacted.
- 38:42Bob Miller: That's why two people can live in a moldy house.
- 38:45Bob Miller: One person is sick and the other one says, but I don't feel anything.
- 38:49Bob Miller: There's the difference.
- 38:52Bob Miller: Then here comes your hydroxyl radicals again.
- 38:54Bob Miller: I think this is our first.
- 38:56Bob Miller: Our first podcast.
- 38:57Bob Miller: Six years ago, we spoke about how hydrogen peroxide combines with iron in the Fenton reaction and makes these hydroxyl radicals.
- 39:09Bob Miller: Now, if we're able to have enough catalase thyrodoxin or glutathione peroxidase 4, we can burn that off.
- 39:17Bob Miller: But again, you can have genetic snips in these guys that you don't clear the hydrogen peroxide, you're going to be more prone for this.
- 39:25Bob Miller: And what do you have?
- 39:26Bob Miller: Cardiolipin oxidation.
- 39:28Bob Miller: Then impaired electron transport efficiency.
- 39:31Bob Miller: More electron leaks, weaker proton gradients, less ATP.
- 39:38Bob Miller: And around we go.
- 39:41Bob Miller: Now, what happens next is fascinating.
- 39:45Bob Miller: We all know that calcium is, you know, critical for the body.
- 39:49Bob Miller: It builds the teeth and the bones, but it's also a signaling molecule.
- 39:54Bob Miller: It'll signal things.
- 39:55Bob Miller: So when you move your hand or your heartbeats, the calcium is the one that signals it to do that.
- 40:04Bob Miller: But anything can be excessive.
- 40:06Bob Miller: Back to our Goldilocks.
- 40:08Bob Miller: And there's an enzyme called RYR1 that takes calcium from something called the endoplasmic reticulum, which does a lot of things, but one of the things, it's the storehouse for calcium.
- 40:21Bob Miller: And when stimulated here it says when it's excessively stimulated, the cytosolic calcium rises, creating a stronger calcium signal near the mitochondria.
- 40:31Bob Miller: The mitochondria then take out more calcium through this enzyme increasing.
- 40:36Bob Miller: And then they're saying, excessive matric calcium can promote oxidative stress, impair the electron transport chain, and reduce efficient ATP production.
- 40:46Bob Miller: So calcium can be your best friend or your worst enemy, like everything can be.
- 40:52Bob Miller: So this RYR one can be stimulated by lipid peroxidation.
- 40:59Bob Miller: Whoa.
- 41:01Dr. Jill Carnahan: Yes.
- 41:01Bob Miller: So lipid peroxidation will tell this guy, dump out calcium.
- 41:06Bob Miller: Well, then what does it do?
- 41:09Bob Miller: So it says,.
- 41:11Dr. Jill Carnahan: And, Bob, will we actually see hypercalcemia in the serum, or is this just a process that's intracellular that we couldn't measure?
- 41:18Dr. Jill Carnahan: Do we know?
- 41:19Bob Miller: I'm not sure.
- 41:20Bob Miller: But just interestingly now, this is just.
- 41:23Bob Miller: Yeah, clinical observation.
- 41:24Bob Miller: This is all it is when I point this out.
- 41:27Bob Miller: These people do have high calcium in the blood.
- 41:30Dr. Jill Carnahan: Well, we already know, like, cancer situations and we call them metaneoplastic syndromes, which are things that go alongside, not that always means there's cancer, but when there's damage and growth in the body, often this hypercalcemia is one of the things that can happen again, among other things.
- 41:46Dr. Jill Carnahan: So that makes sense.
- 41:49Bob Miller: So here we go.
- 41:50Bob Miller: Lipid peroxidation generates reactive oxidants and aldehydes that can modify that RYR one.
- 41:58Bob Miller: Oh, my goodness.
- 41:59Bob Miller: Let me say that again.
- 42:00Bob Miller: Lipid peroxidation modifies ryr1, making the channel more prone to calcium leakage from the endoplasmic reticulum.
- 42:09Bob Miller: The resulting rise increases mitochondrial calcium uptake, primarily through that mcu, and that increases more reactive oxygen species, promotes mitochondrial permeability changes, disrupts electron flow through the electron transport chain.
- 42:25Bob Miller: And here we go.
- 42:26Bob Miller: Decreases your ATP production while increasing leakage and oxidative stress.
- 42:33Bob Miller: You see how we've got a couple of feedback loops going on here, Dr. Jill?
- 42:37Dr. Jill Carnahan: Yes.
- 42:40Bob Miller: All right, then here's what happens when we get that calcium overload.
- 42:45Bob Miller: Here's your endoplasmic reticulum.
- 42:48Bob Miller: Ryr1 becomes overactive, puts too much calcium in the cytosolic area, goes into the mitochondria, and then that creates mitochondrial dysfunction, oxidative stress, er, stress.
- 43:04Bob Miller: There's something called calpain that we can get into later.
- 43:07Bob Miller: Inflammation, excitability problems, muscle dysfunction, cardiac stress, cell injury and apoptosis, all that can occur when this guy is pumping out too much calcium.
- 43:22Dr. Jill Carnahan: Wow.
- 43:22Bob Miller: And then we'll talk later.
- 43:23Bob Miller: There's an enzyme called ncx, which helps take the calcium out, but that will be weakened if there's not enough ATP.
- 43:32Bob Miller: That's.
- 43:32Bob Miller: We're going to go here next.
- 43:35Bob Miller: So now we're going to move over to the sodium potassium pump.
- 43:39Bob Miller: And quite simply, what that does, it keeps the balance of sodium and potassium.
- 43:44Bob Miller: So you need potassium inside the cell and not too much sodium.
- 43:51Bob Miller: And this pump is an ATP dependent membrane that moves three sodium ions out of the cell, two potassiums into the cell, maintaining the electrical and chemical gradients needed for normal cellular function.
- 44:04Bob Miller: Look what it does.
- 44:05Bob Miller: Nerve signaling, muscle contraction, nutrient transport, cell volume control, secondary transport systems such as calcium and neurotransmitter handling.
- 44:14Bob Miller: Talk about that stress a little bit later.
- 44:17Bob Miller: Yeah.
- 44:17Bob Miller: When the pump is impaired, sodium can accumulate inside the cell.
- 44:21Bob Miller: Potassium gradients, weakened calcium regulations become disrupted and neurons and muscles may become electrically unstable, contributing to impaired signaling, weakness, excitability and further cellular stress.
- 44:35Bob Miller: And guess who this guy runs on ATP.
- 44:41Bob Miller: So we're not going to read all of this here, but here's the.
- 44:44Bob Miller: Here's the sodium potassium pump.
- 44:48Bob Miller: Taking out sodium, bringing in potassium, running off ATP consequences, brain and nerves, heart, muscles, kidneys, intestines, all of those can be impacted if we don't have this guy doing its job.
- 45:04Bob Miller: Now over here, you see the enzymes that are part of that and genetic SNPs here can further impact how the sodium potassium pump does its job.
- 45:15Bob Miller: So one of the easiest ways to see that is when people have edema, the swelling of the ankles, they're getting that sodium potassium out of balance.
- 45:24Bob Miller: Now here's how we take care of the calcium.
- 45:28Bob Miller: There's an enzyme called circa that puts the calcium back into the endoplasmic reticulum.
- 45:36Bob Miller: But look who it's dependent upon.
- 45:38Dr. Jill Carnahan: ATP seems like a common theme here, Bob, we need that ATP.
- 45:43Dr. Jill Carnahan: We sure do.
- 45:46Bob Miller: So then if your sodium potassium pump doesn't work, it doesn't create the right gradient so NCX can take the calcium out.
- 45:56Bob Miller: And then you're going to have all this cellular stress, impaired relaxation, mitochondrial strain, dysfunctional injury if circa is not doing its job and the sodium potassium pump was weak, all depended upon ATP.
- 46:15Bob Miller: So this is just another drawing of the circa that if you got adequate ATP, you're going to put this calcium back into the endoplasmic reticulum.
- 46:25Bob Miller: If it's not doing its job, it stays in the cytosol, creating all the problems that it creates.
- 46:33Bob Miller: Now listen to this.
- 46:34Bob Miller: It makes neurons more excitable and that's going to make you stressed.
- 46:41Bob Miller: So you can see how this just becomes a chain of events that keeps impacting.
- 46:46Bob Miller: So the brain and nervous system, the lungs, the muscles, the intestines, the heart, they're all impacted if that's not working properly.
- 46:56Bob Miller: So here's.
- 46:57Bob Miller: And again, I'm not going to read all this.
- 46:59Bob Miller: We could spend a whole webinar on this one.
- 47:01Bob Miller: But it just shows how the sodium potassium pump's going to affect the neurons homeostasis and enabling every thought, signal and movement in the brain.
- 47:12Bob Miller: It's the foundation for stable neurons, healthy signaling and brain resilience.
- 47:19Bob Miller: For the heart, it's the foundation for healthy rhythm, contraction and cardiac resilience.
- 47:29Bob Miller: Then also for the lungs, supports healthy airway function, cellular stability and lung resilience.
- 47:37Bob Miller: For the muscles supporting strength, relaxation and muscle resilience.
- 47:41Bob Miller: As people get older, that's one of their Biggest concerns that they don't have the strength to stay stable, to walk properly, to fall.
- 47:48Bob Miller: Because you know, one fall at a certain age can really be serious if you break a hip.
- 47:53Bob Miller: So if you want those muscles to be working, you got to make sure they have enough ATP.
- 47:58Bob Miller: And this sodium potassium pump is doing its job.
- 48:03Bob Miller: And finally the intestines supports motility, absorption and intestinal resilience.
- 48:08Bob Miller: And finally the kidneys, Healthy kidney cells, balanced electrolytes, stable blood pressure, long term kidney protection, all of that is dependent upon that.
- 48:19Bob Miller: So when that's inadequate loss of membrane stability, calcium may be cleared less effectively, cells may swell.
- 48:26Bob Miller: I'm sure you see a lot of people, they've got swollen ankles.
- 48:30Bob Miller: Nerves, muscles, heart tissue and other high energy organs may function less efficiently.
- 48:34Bob Miller: And as the ATP falls, lump function slows.
- 48:39Bob Miller: All right, now you had said earlier you were excited about stress.
- 48:42Dr. Jill Carnahan: Yeah.
- 48:43Bob Miller: Okay, so there's something called an astrocyte.
- 48:48Bob Miller: And astrocytes take glutamate.
- 48:51Bob Miller: Now glutamate makes you intelligent, highly motivated, go getter.
- 48:55Bob Miller: But in excess creates anxiety, neuroinflammation.
- 49:00Bob Miller: Can't sleep, it's a mess.
- 49:02Bob Miller: If the glutamate is too high.
- 49:04Bob Miller: Again, Goldilocks, yes.
- 49:07Bob Miller: Not too much, not too little.
- 49:11Bob Miller: So if we have adequate ATP, you see that up top here, it actually creates a gradient where what happens is that sodium grabs the glutamate and brings it in if there's low sodium inside here.
- 49:25Bob Miller: And then this enzyme the takes the glutamate, turns it into glutamine, which is an amino acid that actually helps make glutathione and it goes back out as glutamine.
- 49:41Bob Miller: So the excitatory glutamate turns into the helpful glutamine through the astrocyte.
- 49:48Bob Miller: That's contingent upon the sodium potassium pump keeping that sodium and potassium balanced so that it will flow in.
- 50:00Bob Miller: So what happens if we don't have it?
- 50:04Bob Miller: Oh, and by the way, I forgot to mention that it's not just glutamate, it's ammonia.
- 50:11Bob Miller: So there's some researchers that believe this is why autistic children do flapping, because of the ammonia and the glutamate together.
- 50:20Bob Miller: So wouldn't that be something if autism was actually an ATP problem?
- 50:25Bob Miller: So now here is the astrocyte where we don't have enough potassium and we have too much sodium, the glutamate remains outside, doesn't come in here, very little goes out as glutamine.
- 50:44Bob Miller: And then you're going to have pulling less glutamate in and Then the glutamate remains high and you're going to be stressed.
- 50:53Bob Miller: That's the astrocyte.
- 50:55Bob Miller: Now here's the neuron, so the neurons.
- 51:00Bob Miller: I'm sure everybody's heard of gaba.
- 51:02Bob Miller: GABA is the don't worry, relax, be happy.
- 51:05Bob Miller: And some people take GABA and they're relaxed.
- 51:08Bob Miller: And some people take GABA and say, it made me worse.
- 51:11Bob Miller: Did you ever hear that?
- 51:13Dr. Jill Carnahan: Oh, yes, because I know this pathway well, I do have patients that can't take gaba.
- 51:18Bob Miller: So what happens?
- 51:19Bob Miller: GABA has one job and one job only.
- 51:22Bob Miller: It opens up the GABA receptor, so chloride can flow in.
- 51:29Bob Miller: But for the chloride to flow in, you have to have low chloride inside.
- 51:35Bob Miller: And guess who does that?
- 51:36Bob Miller: There's enzymes called KCC2 and NKCC1.
- 51:40Bob Miller: So KCC2 keeps the intracellular calcium low.
- 51:45Bob Miller: NKCC1 brings it in.
- 51:49Bob Miller: Guess who controls it?
- 51:51Bob Miller: The sodium potassium pump that needs ATP.
- 51:56Bob Miller: So if everything's working fine, GABA hits chloride, moves in.
- 52:03Bob Miller: relaxing.
- 52:05Bob Miller: However, if we don't have enough ATP and the sodium potassium balance gets off, there's high chloride inside.
- 52:16Bob Miller: GABA hits chloride, rather than going in, moves out.
- 52:21Bob Miller: And that's excitatory.
- 52:24Bob Miller: And we want to do some research on this, but this very well may be happening with a lot of anxiety disorders and even autism.
- 52:32Bob Miller: Not saying that yet, but that needs to be researched.
- 52:34Dr. Jill Carnahan: That makes a lot of sense because I find glutamate being high in this GABA issue in patients who have, like you said, it's sometimes on the spectrum or other things.
- 52:44Dr. Jill Carnahan: And this glutamate, GABA thing are all about mood disorders and sleep.
- 52:51Bob Miller: Absolutely.
- 52:52Bob Miller: So as we said, that's why people can take gaba.
- 52:54Bob Miller: Somebody tells them, oh, you're stressed, take gaba.
- 52:56Bob Miller: And it's like it made me worse because it did what it's supposed to do.
- 53:00Bob Miller: GABA has one job.
- 53:02Bob Miller: Open up this channel.
- 53:04Bob Miller: Yes.
- 53:04Bob Miller: And if the chloride is low inside, it flows in.
- 53:09Bob Miller: It's relaxing.
- 53:10Bob Miller: If it's high inside, it goes the other direction and it's excitatory.
- 53:15Bob Miller: Yeah.
- 53:17Bob Miller: So ATP doesn't just power the cell, it determines which systems fail first.
- 53:25Bob Miller: So we need to start asking which ATP dependent systems are failing.
- 53:29Bob Miller: So here's the cardiolipin story.
- 53:31Bob Miller: Cardiolipin organizes the electron transport chain.
- 53:35Bob Miller: Then it produces the ATP, powers nearly every biological process.
- 53:40Bob Miller: When cardiolipin is damaged, they fail in predictable patterns all the way to clinical manifestations physicians see every day.
- 53:49Bob Miller: It's a compelling system biology narrative that ties together mitochondrial function, inflammation, organ dysfunction in a Single network.
- 53:59Bob Miller: So when you got low ATP, it forces cells to reduce non essential functions, preserve membrane integrity, maintain ion gradients, limit biosynthesis.
- 54:09Bob Miller: Physicians often see the downstream effects.
- 54:12Bob Miller: Fatigue, organ dysfunction, metabolic influx, inflexibility, sometimes without recognizing the mitochondrial origin.
- 54:23Bob Miller: So, ATP deficiency, we talked about the electrical failure, neurological, muscular, immune failure, genetic failure, structural failure, recycling failure, detoxification failure, organ failure.
- 54:36Bob Miller: Now, this is a chart that I just literally finished last night.
- 54:40Dr. Jill Carnahan: Wow.
- 54:41Bob Miller: Maybe I'm being a little brave here, but I'm saying redefining functional medicine.
- 54:46Bob Miller: So here's your infections, your Lyme, your mycotoxins, your spike protein, your EMF, your pollutants, chronic stress, they stimulate microglia, M1, tumor necrosis factor NF, kappa B.
- 55:00Bob Miller: Here's Carnahan reaction.
- 55:03Bob Miller: Peroxonitrite damages the cardiolipin lipid bilayer, mitochondrial damage, electron leak, superoxide that then combines with hydrogen peroxide, hydroxyl radicals, lipid peroxidation.
- 55:19Bob Miller: Okay.
- 55:21Bob Miller: And feedback loop, Then iron, sulfur clusters.
- 55:25Bob Miller: If they're not doing their job, more iron may participate in the Fenton reaction.
- 55:31Bob Miller: Then again, electron transport, chain activity goes down, all of it pointing to low ATP production.
- 55:40Bob Miller: That's going to affect the sodium potassium pump.
- 55:43Bob Miller: Then we get a problem there.
- 55:45Bob Miller: And then comes the calcium.
- 55:47Bob Miller: And then here's your impaired astrocytes and neurons.
- 55:51Bob Miller: Anxiety and hyperbility, hyperexcitability and anxiety.
- 55:56Bob Miller: And then that glutamate dysregulation causes more cellular damage.
- 56:00Bob Miller: And around we go.
- 56:02Bob Miller: So I literally just had this.
- 56:05Dr. Jill Carnahan: Fascinating.
- 56:06Dr. Jill Carnahan: I love it so much.
- 56:08Dr. Jill Carnahan: Makes so much sense.
- 56:09Dr. Jill Carnahan: Bob.
- 56:09Dr. Jill Carnahan: Yeah.
- 56:10Bob Miller: I'll probably be redefining this a little bit over time, but I think this captures the bulk of it.
- 56:14Dr. Jill Carnahan: I was gonna say this is so much that I think we should have a part two and kind of go over like in a few months of what has changed, if there's been any little.
- 56:21Dr. Jill Carnahan: Because this is just fascinating.
- 56:22Dr. Jill Carnahan: I think the cell membrane concept, ATP at the core is really where we should be at, really.
- 56:27Dr. Jill Carnahan: Molecular medicine, but personalized precision.
- 56:30Dr. Jill Carnahan: This is where it's at.
- 56:32Bob Miller: Absolutely.
- 56:33Dr. Jill Carnahan: Now, I don't know if you want to share.
- 56:35Dr. Jill Carnahan: We've got about five minutes left.
- 56:36Dr. Jill Carnahan: So you can decide what's most priority.
- 56:38Bob Miller: But what we'll do, we'll go through action steps very quickly.
- 56:42Dr. Jill Carnahan: You got it.
- 56:43Bob Miller: A quick peek at you.
- 56:44Dr. Jill Carnahan: Okay, sounds good.
- 56:46Bob Miller: Inflammatory triggers the tnfa, restore calcium homeostasis, protect the cardiolipin, the support cardiolipin synthesis, limit hydrogen peroxide, support the electron transport cofactors.
- 57:01Bob Miller: And we could probably do a whole webinar on that.
- 57:03Bob Miller: Just Very quickly, if anyone wants to take a peek at the genetic side, that's what we do.
- 57:08Bob Miller: We do functional genetic testing.
- 57:10Bob Miller: And if somebody wants to get our clinic here we are Tree of Life Health to l health.com we can measure your genetics, do a consult, find out where your weakness is.
- 57:20Bob Miller: And then for practitioners, if they would like to do this, here's where a practitioner can go ahead and do this.
- 57:27Bob Miller: Functionalgenomicanalysis.com now let's take a really quick peek at you, Dr. Jill.
- 57:32Dr. Jill Carnahan: Sounds good.
- 57:33Dr. Jill Carnahan: And I just want to say, Bob, your work here in training physicians and helping patients has been so profound.
- 57:39Dr. Jill Carnahan: So I'm really glad to share this information.
- 57:41Dr. Jill Carnahan: Every single episode that we do because it's the going to this level often gives an insight or aha.
- 57:47Dr. Jill Carnahan: Into these small.
- 57:48Dr. Jill Carnahan: Like the Carnahan reaction.
- 57:49Dr. Jill Carnahan: Right, One of these things that.
- 57:51Dr. Jill Carnahan: Exactly.
- 57:52Bob Miller: Okay, now this is Dr. Jill and this is on our functional genomic analysis.
- 57:59Bob Miller: So what triggers it is if we absorb extra iron.
- 58:03Bob Miller: And if you remember your heterozygous for the hemochromatosis gene.
- 58:07Dr. Jill Carnahan: Yes.
- 58:08Bob Miller: Then you also have SLC 40 a one that could give us more iron.
- 58:13Bob Miller: This would be a topic all itself.
- 58:15Bob Miller: But there's an enzyme called hepherd.
- 58:17Bob Miller: It helps take the Fe2 into the Fe3.
- 58:19Bob Miller: And you can see you got a couple snips there that stimulates TNFA, NF, Kappa B, Interleukin 6.
- 58:29Bob Miller: And here's Carnahan reaction 2 right here.
- 58:33Bob Miller: Increase excess super ox nitric oxide.
- 58:36Bob Miller: Again, nitric oxide is not bad.
- 58:38Bob Miller: People get very upset that you're saying nitric oxide's bad.
- 58:41Bob Miller: Not at all.
- 58:42Bob Miller: But when it combines with superoxide, that's when it makes the peroxy nitrite that damages the cell membranes.
- 58:50Bob Miller: Then over here, if we don't clear hydrogen peroxide.
- 58:55Bob Miller: And you can see here you've got one homozygous on catalase.
- 58:58Bob Miller: You'll get hydroxyl radicals.
- 59:00Bob Miller: That makes lipid peroxidation.
- 59:02Bob Miller: And you're in one feedback loop here.
- 59:06Bob Miller: Now remember we said that stimulates the RYR1 enzyme to push calcium in to the mitochondria.
- 59:18Bob Miller: So this is your complexes here.
- 59:20Bob Miller: So no matter what's going on with the ingredients that are needed for this, if that calcium comes rushing in, it shuts it down.
- 59:28Bob Miller: Okay, then here you can see, these are the enzymes that make the cardiolipin.
- 59:33Bob Miller: But you also, if you remember I told you need the long chain polyunsaturated fatty acids.
- 59:37Dr. Jill Carnahan: Yes.
- 59:39Bob Miller: And you can see it's not real bad, but you have some snips here on Fads 2.
- 59:44Bob Miller: Your Fads 1 is looking fine.
- 59:46Bob Miller: So you really don't have any trouble I don't believe getting the nutrients there to make the cardiolipin.
- 59:53Bob Miller: But your challenge might be that because of the lipid peroxidation the calcium is coming in.
- 1:00:00Bob Miller: Now I'm really excited about the iron sulfur cluster.
- 1:00:05Dr. Jill Carnahan: huh.
- 1:00:06Bob Miller: So here you can see the making of the iron sulfur cluster.
- 1:00:10Bob Miller: Okay.
- 1:00:10Bob Miller: Now we've not identified which of these are evidence based yet.
- 1:00:14Bob Miller: So we don't know.
- 1:00:15Bob Miller: But you can see here you've got two little snips on the guy that delivers the NADPH to make the iron sulfur cluster.
- 1:00:26Bob Miller: But remember I said once you make it, you can oxidize it.
- 1:00:31Bob Miller: And again not a diagnosis but a predisposition here Dr. Joe, that because you're a little weakness on nerf on nrf2 and you've got a little weakness on HMOX and little extra push on NF Kappa B.
- 1:00:47Bob Miller: But here's the one, the Nos 2, yes.
- 1:00:49Bob Miller: If you're making any superoxide that's going to make peroxonitrite which is going to damage your iron sulfur cluster, then this guy right here, you can see you've got a homozygous on all three of them.
- 1:01:03Bob Miller: That's the one that takes the iron sulfur cluster and delivers it to complex number one.
- 1:01:09Bob Miller: Wow.
- 1:01:11Bob Miller: So yeah, you can see there's a second component here to the.
- 1:01:18Bob Miller: Yeah to that Nos 2.
- 1:01:20Bob Miller: That again not a diagnosis but a potential that you might be damaging those iron sulfur clusters just a little bit.
- 1:01:29Bob Miller: Wow.
- 1:01:30Dr. Jill Carnahan: Makes sense.
- 1:01:30Dr. Jill Carnahan: We just, like we said, we just keep getting deeper and more layers and this is fascinating.
- 1:01:37Dr. Jill Carnahan: So if you're out there listening, like I said, Bob started in the beginning, please go back.
- 1:01:40Dr. Jill Carnahan: It's almost like we've created a whole course of episodes.
- 1:01:44Dr. Jill Carnahan: Go back to the episode that he first mentioned and listen to that.
- 1:01:48Dr. Jill Carnahan: He has them all listed in earlier in this, you can just rewind if you're listening audio or video.
- 1:01:53Dr. Jill Carnahan: And then this to me though is the cherry on the top.
- 1:01:57Dr. Jill Carnahan: Right.
- 1:01:57Dr. Jill Carnahan: Like this is one of those things that you told me beforehand would be profound.
- 1:02:01Dr. Jill Carnahan: And because I'm also seeing this in clinical practice with more anticardiolipin antibodies and more inflammation and just lipid membranes in general being the core of how we often reverse some of this complex chronic issues.
- 1:02:15Dr. Jill Carnahan: I really love going to that level versus being up here and the infections and toxins.
- 1:02:19Bob Miller: Right, Yeah, I think that's the whole point of this, we perhaps we're just going too far down.
- 1:02:25Bob Miller: And I wouldn't be surprised that Covid has made it happen.
- 1:02:29Dr. Jill Carnahan: Yes.
- 1:02:31Bob Miller: That's what's driving it now.
- 1:02:32Bob Miller: And then mold getting stronger, Lyme getting stronger.
- 1:02:35Bob Miller: And we're just doing.
- 1:02:37Bob Miller: I help doctors many times go through the genetics, and they keep telling me things that used to work in the past don't work as well.
- 1:02:43Dr. Jill Carnahan: Yes, that's exactly.
- 1:02:44Dr. Jill Carnahan: I often say, you know, I'd have these very simple patients in three months, they'd be, well, 20 plus years ago.
- 1:02:49Dr. Jill Carnahan: And now it doesn't happen that way.
- 1:02:51Dr. Jill Carnahan: It's way more complex and more layers.
- 1:02:53Dr. Jill Carnahan: So, Bob, as always, I am so grateful for you, for our friendship.
- 1:02:58Dr. Jill Carnahan: I'm so grateful for the brilliance that you bring to this.
- 1:03:00Dr. Jill Carnahan: And I love these very special episodes because they really dive deep.
- 1:03:03Dr. Jill Carnahan: And those people who want that are watching and listening.
- 1:03:06Dr. Jill Carnahan: And if you guys have enjoyed this or find it helpful, please share it with a friend or your physician, please.
- 1:03:12Dr. Jill Carnahan: Pretty please.
- 1:03:13Dr. Jill Carnahan: Bob, as always, we're going to do another.
- 1:03:14Dr. Jill Carnahan: We're going to do round two around three, around 27.
- 1:03:18Bob Miller: So couple rounds on every.
- 1:03:20Bob Miller: Because we really just touched the surf.
- 1:03:21Bob Miller: We could do.
- 1:03:22Dr. Jill Carnahan: Exactly.
- 1:03:22Dr. Jill Carnahan: I'm like, this is so good and it's so deep.
- 1:03:24Dr. Jill Carnahan: Like, I'm going to have to go and watch it again.
- 1:03:26Dr. Jill Carnahan: So if you're out there listening, you may want to rewind and listen again.
- 1:03:28Dr. Jill Carnahan: But as always, thank you for your brilliant research.
- 1:03:31Dr. Jill Carnahan: Thank you for bringing this to the field, and I hope to see you upcoming in person at one of the conferences.
- 1:03:36Bob Miller: Absolutely.
- 1:03:37Bob Miller: All right, well, take care, my friend, and we'll.
- 1:03:38Bob Miller: We'll talk again soon.
- 1:03:40Dr. Jill Carnahan: Thank you, Bob.